| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
In Vitro Pathogenesis Section, Laboratory of Experimental Pathology, National Cancer Institute, Bethesda, Maryland 20205 [H. H., B. F., N. H. C., G. T. B., S. H. Y.]; Microbiological Associates, Bethesda, Maryland 20016 [D. D., M. L. W.]; Biology Division, Oak Ridge National Laboratories, Oak Ridge, Tennessee 37836 [T. J. S.]; and Institute for Pathology, Rikshospitalet, Oslo, Norway [K. E.]
In order to define factors which determine susceptibility to chemical carcinogenesis, mice sensitive (SENCAR) and resistant (BALB/c) to epidermal carcinogenesis were studied under several treatment conditions for sensitivity to initiation by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine and promotion by 12-O-tetradecanoylphorbol-13-acetate. In newborns of both strains, topical application of initiator was much less effective than in adults. However, initiation by i.p. injection of 7,12-dimethylbenz(a)anthracene is at least as effective in newborns as in adults, which may indicate that topically applied carcinogen is not delivered effectively to target cells in newborns. Thus, newborn epidermis can respond to 7,12-dimethylbenz(a)anthracene as well as adult epidermis when the initiator is appropriately administered. SENCAR mice are much more sensitive than are BALB/c mice to both initiators, which suggests that enhanced metabolic activation of hydrocarbon carcinogens by SENCAR mice is unlikely to account for their sensitivity. Newborn male SENCAR's developed approximately 50% more papillomas than did females in all groups. BALB/c newborn mice developed so few tumors that a meaningful comparison of sensitivity of males and females could not be made. Thus, the increased sensitivity of SENCAR's was apparent regardless of route of administration of initiator or the age or sex of the mice. SENCAR mice also developed a significant number of papillomas and squamous cell carcinomas with 12-O-tetradecanoylphorbol-13-acetate promotion in the absence of an exogenous initiator. Therefore, the skin of SENCAR mice may contain an initiated population of cells capable of responding to tumor promoters.
1 To whom requests for reprints should be addressed, at NIH, Building 37, Room 3A21, Bethesda, Md. 20205.
Received 7/14/80. Accepted 11/11/80.
This article has been cited by other articles:
![]() |
K. Ridd, S.-D. Zhang, R. E. Edwards, R. Davies, P. Greaves, A. Wolfreys, A. G. Smith, and T. W. Gant Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin Carcinogenesis, August 1, 2006; 27(8): 1556 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Woodworth, E. Michael, L. Smith, K. Vijayachandra, A. Glick, H. Hennings, and S. H. Yuspa Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte Carcinogenesis, September 1, 2004; 25(9): 1771 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Hansen, D. Brown, V. Virador, T. Tanaka, F. Andreola, K. Strain, B. Dancheck, R. Riley, J. M. Arbeit, L. M. De Luca, et al. A PMLRARA Transgene Results in a Retinoid-deficient Phenotype Associated with Enhanced Susceptibility to Skin Tumorigenesis Cancer Res., September 1, 2003; 63(17): 5257 - 5265. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Han, K. Fukamachi, N. Takasuka, T. Ohnishi, M. Maeda, T. Yamasaki, and H. Tsuda Inhibitory effects of 17{beta}-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats Carcinogenesis, July 1, 2002; 23(7): 1209 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyata, G. Kudo, Y.-H. Lee, T. J. Yang, H. V. Gelboin, P. Fernandez-Salguero, S. Kimura, and F. J. Gonzalez Targeted Disruption of the Microsomal Epoxide Hydrolase Gene. MICROSOMAL EPOXIDE HYDROLASE IS REQUIRED FOR THE CARCINOGENIC ACTIVITY OF 7,12-DIMETHYLBENZ[a]ANTHRACENE J. Biol. Chem., August 20, 1999; 274(34): 23963 - 23968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.W. Dean, T.M. Brooks, B. Burlinson, J. Mirsalis, B. Myhr, L. Recio, and V. Thybaud Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens Mutagenesis, January 1, 1999; 14(1): 141 - 151. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |